News

Today we celebrate Stem Cell Awareness Day and salute all of our peers working to realise the therapeutic potential of stem cell-d...

bit.bio appoints new Chief Financial Officer, Przemek Obloj

Discover how a collaboration delivered bit.bio's ioGlutamatergic Neurons onto the stage at the Royal Institution to appear in the ...

bit.bio received a gold award for its participation in the Green Impact awards for sustainability.

bit.bio's President and COO named as one of the 20 women reshaping biopharma R&D in 2023 report.

bit.bio is partnering with the iGEM student competition, aimed at advancing the field of synthetic biology.

Our VP of R&D Manos Metzakopian writes in Innovations in Pharmaceutical Technology about novel technologies that enable researcher...

Device that could restore limb function to amputees and others who have lost the use of their arms or legs uses opti-ox reprogramm...